Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Hua Medicine Limited

Clinical trials sponsored by Hua Medicine Limited, explained in plain language.

Hua Medicine 2552 HKEX

Hua Medicine is a biopharmaceutical company developing innovative therapies for diabetes and other metabolic diseases.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Completed 1

Diabetes drug dorzagliatin under Long-Term safety watch

Disease control Completed

This study tracks the long-term safety of dorzagliatin, a drug for type 2 diabetes, in over 2,000 patients over 52 weeks. Researchers monitor side effects and how well the drug controls blood sugar. The goal is to ensure the drug remains safe for everyday use.

Phase: PHASE4 • Sponsor: Hua Medicine Limited • Aim: Disease control

Last updated Jul 12, 2026 00:00 UTC